0001093557-16-000678.txt : 20160909 0001093557-16-000678.hdr.sgml : 20160909 20160909205023 ACCESSION NUMBER: 0001093557-16-000678 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160907 FILED AS OF DATE: 20160909 DATE AS OF CHANGE: 20160909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 161879836 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-09-07 0 0001093557 DEXCOM INC DXCM 0001236389 FOLETTA MARK G 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 1 0 0 0 Common Stock 2016-09-07 4 S 0 1800.0 94.625 D 15643 D This transaction was executed in multiple trades at prices ranging from $94.60 to $94.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 10,027 unvested restricted stock units, 5,450 of which were granted on May 25, 2016 and shall vest on May 25, 2017 and 4,577 of which were granted on November 17, 2014 and shall vest through November 17, 2017. By: Jess Roper For: Mark G. Foletta 2016-09-09